Tracy Swan, presented at HEP DART 2009

Table of Contents

Credits Acknowledgements Dedication Foreword

Volume I: Clinical Science

Executive Summary Introduction I. Epidemiology of Hepatitis C II. Natural History of Hepatitis C III. Natural History of HCV in HIV Coinf...

Adverse Events & Comorbidities

Hepatitis C Virus (HCV) and HIV/HCV Coinfection: A Critical Review of Research and Treatment

Tracy Swan, presented at HEP DART 2009; Bob Huff; Treatment Action Group

5 Min Read

Table of Contents

Credits Acknowledgements Dedication Foreword

Volume I: Clinical Science

Executive Summary Introduction I. Epidemiology of Hepatitis C II. Natural History of Hepatitis C III. Natural History of HCV in HIV Coinf...

Adverse Events & Comorbidities

Cure Rates With Pipeline HCV Drugs: Reports From AASLD

Tracy Swan, presented at HEP DART 2009; HIV i-Base

13 Min Read

It is difficult to be anything other than dazzled by astounding cure rates of up to 100% from a multitude of interferon-free hepatitis C virus (HCV) clinical trials presented at the American Association for the Study of Liver Diseases (AASLD) meeting...

Adverse Events & Comorbidities

Cure Rates With Pipeline HCV Drugs: Reports From AASLD

Tracy Swan, presented at HEP DART 2009; HIV i-Base

13 Min Read

Adverse Events & Comorbidities

What You Don't Know, You Can Sell

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

5 Min Read

Many people with HIV also have hepatitis C. So why did it take so long to see information about potentially serious interactions between HIV drugs and Victrelis (boceprevir), a new hep C medication? Activist Tracy Swan offers this sharp critique.

Adverse Events & Comorbidities

What You Don't Know, You Can Sell

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

5 Min Read

Adverse Events & Comorbidities

The Hepatitis C Treatment Pipeline

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

18 Min Read

Table of Contents

The Thrill Is Already Gone Evolution to Revolutionary? Clinical Issues in the United States Access Issues Diagnostics Research Issues Plea for Simplicity Most Need, Least Data Drug-Drug Interactions Current Resear...

Adverse Events & Comorbidities

The Hepatitis C Treatment Pipeline

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

18 Min Read

Table of Contents

Adverse Events & Comorbidities

Guide to Clinical Trials for People With Hepatitis C

Tracy Swan, presented at HEP DART 2009; Matt Sharp; Treatment Action Group

2 Min Read

There are many new hepatitis C drugs being studied in clinical trials. People with hepatitis C have many options to choose from. Whether you have hepatitis C or another medical condition, deciding to participate in a clinical trial can be complicated...

Adverse Events & Comorbidities

Guide to Clinical Trials for People With Hepatitis C

Tracy Swan, presented at HEP DART 2009; Matt Sharp; Treatment Action Group

2 Min Read

Adverse Events & Comorbidities

Access to Hepatitis C Treatment: A Global Movement Gains Momentum

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

6 Min Read

Being a person living with HIV/AIDS, hepatitis C, and an injection drug user, I look at my body. People want to treat my virus -- my immune system -- people want to treat my chest -- my TB -- but no one wants to treat my liver, so we have to find som...

Adverse Events & Comorbidities

Access to Hepatitis C Treatment: A Global Movement Gains Momentum

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

6 Min Read

Adverse Events & Comorbidities

Terms For Response to HCV Treatment

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

3 Min Read

Treatment Response: Response to hepatitis C treatment is measured by change in HCV viral load at different time points. Since it is a common practice to release interim data from HCV treatment trials, it is important to understand what these terms me...

Adverse Events & Comorbidities

Terms For Response to HCV Treatment

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

3 Min Read

Adverse Events & Comorbidities

Rapidly Progressing Hepatitis C in New York Gay Men

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

4 Min Read

Recent outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have sex with men (MSM) have been reported in England, France, Germany, Holland, and the United States. Many of these cases were sexually transmitted, which is unusual becau...

Adverse Events & Comorbidities

Rapidly Progressing Hepatitis C in New York Gay Men

Tracy Swan, presented at HEP DART 2009; Treatment Action Group

4 Min Read

Adverse Events & Comorbidities

HIV Drugs and HCV Infection

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

2 Min Read

HIV Drugs and HCV Infection

Although coinfected people are at risk for liver toxicity from ARVs, the benefit of HIV treatment outweighs the risk for liver toxicity.

Some side effects are more common in people with HCV coinfection, including lipodys...

Adverse Events & Comorbidities

HIV Drugs and HCV Infection

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

2 Min Read

HIV Drugs and HCV Infection

Although coinfected people are at risk for liver toxicity from ARVs, the benefit of HIV treatment outweighs the risk for liver toxicity.

Some side effects are more common in people with HCV coinfection, including lipodys...

Adverse Events & Comorbidities

Managing Cirrhosis

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

2 Min Read

Managing Cirrhosis

A damaged liver can still function, but people who have developed cirrhosis are at risk for liver failure and other serious, life-threatening complications. People with compensated cirrhosis should be screened for liver cancer and...

Adverse Events & Comorbidities

Managing Cirrhosis

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

2 Min Read

Managing Cirrhosis

Adverse Events & Comorbidities

Guide to Hepatitis C for People Living With HIV

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

5 Min Read

Living With HCV/HIV Coinfection

Probably the most important aspect of dealing with any medical condition is having time and support to become better informed about choices that affect your health.

Many people who are diagnosed with a chronic diseas...

Adverse Events & Comorbidities

Guide to Hepatitis C for People Living With HIV

Simon Collins; Tracy Swan, presented at HEP DART 2009; Treatment Action Group

5 Min Read

Living With HCV/HIV Coinfection

Probably the most important aspect of dealing with any medical condition is having time and support to become better informed about choices that affect your health.

Many people who are diagnosed with a chronic diseas...

Adverse Events & Comorbidities